Extrapulmonary Presentations of COVID-19 Patients

NCT04896762 | Unknown

• 1 other identifier: Soh-Med-21-04-25
• Study Type: observational
• Target: 948
• Locations: 1 country
• Sites: 1

Brief Summary

An observational study about the extrapulmonary presentations of COVID-19 patients during the second wave of the pandemic.

Conditions

COVID-19

Keywords

extrapulmonary presentation; pulmonary

Outcome Measures

Primary Outcomes (1)

• extrapulmonary presentation in COVID-19

  frequency of extrapulmonary presentation inCOVID-19 second wave pandemic

  Baseline presentation of confirmed cases with COVID-19

Study Arms (2)

Extrapulmonary presentation for COVID-19

patients with confirmed covid 19 disease who primarily presented with extrapulmonary system affection

pulmonary presentation for COVID-19

patients with confirmed covid 19 disease who primarily presented with pulmonary disease

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

patients presented at a triage point in a tertiary health care facility with a suspected covid 19 disease.

You may qualify if:

• all patient with confirmed covid 19 disease presented to our health facility during the second wave of the pandemic

You may not qualify if:

• other diagnosis than covid 19 as a primary cause of presentation of the patient

Sponsors & Collaborators

• Sohag University: lead

Study Sites (1)

Sohag University

Sohag, 82425, Egypt

Location

Related Publications (3)

• Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19. No abstract available.

  PMID: 32087114 BACKGROUND

• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

  PMID: 31986264 BACKGROUND

• Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.

  PMID: 32109013 BACKGROUND

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: assistant professor

Study Record Dates

• First Submitted: May 15, 2021
• First Posted: May 21, 2021
• Study Start: September 1, 2020
• Primary Completion: December 31, 2021
• Study Completion: December 1, 2022
• Last Updated: October 25, 2022

Record last verified: 2022-10

Locations

EG (1)